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Despite an abundance of data describing expression of genes in the Candida albicans ALS
(agglutinin-like sequence) gene family, little is known about the production of Als proteins on
individual cells, their spatial localization or stability. Als proteins are most commonly discussed
with respect to function in adhesion of C. albicans to host and abiotic surfaces. Development of a
mAb specific for Als1, one of the eight large glycoproteins encoded by the ALS family, provided
the opportunity to detect Als1 during growth of yeast and hyphae, both in vitro and in vivo, and to
demonstrate the utility of the mAb in blocking C. albicans adhesion to host cells. Although most C.
albicans yeast cells in a saturated culture are Als1-negative by indirect immunofluorescence, Als1
is detected on the surface of nearly all cells shortly after transfer into fresh growth medium. Als1
covers the yeast cell surface, with the exception of bud scars. Daughters of the inoculum cells,
and sometimes granddaughters, also have detectable Als1, but Als1 is not detectable on cells
from subsequent generations. On germ tubes and hyphae, most Als1 is localized proximal to the
mother yeast. Once deposited on yeasts or hyphae, Als1 persists long after the culture has
reached saturation. Growth stage-dependent production of Als1, coupled with its persistence on
the cell surface, results in a heterogeneous population of cells within a C. albicans culture. Anti-
Als1 immunolabelling patterns vary depending on the source of the C. albicans cells, with obvious
differences between cells recovered from culture and those from a murine model of disseminated
candidiasis. Results from this work highlight the temporal parallels for ALS1 expression and Als1
production in yeasts and germ tubes, the specialized spatial localization and persistence of Als1
on the C. albicans cell surface, and the differences in Als1 localization that occur in vitro and in
vivo.
INTRODUCTION
Candida albicans is an opportunistic fungal pathogen that
causes oral and vaginal mucosal infections as well as
systemic disease. C. albicans has several gene families that
encode proteins involved in host–pathogen interactions
(Jones et al., 2004). Among these is the Als (agglutinin-like
sequence) family of large cell-surface glycoproteins
(reviewed by Hoyer, 2001; Hoyer et al., 2008). Com-
pletion of the genome sequence of C. albicans strain
SC5314 (Jones et al., 2004) has demonstrated that there are
eight different ALS genes located on three of the eight C.
albicans chromosomes (reviewed by Hoyer et al., 2008).
ALS genes share a similar basic organization, consisting
minimally of a relatively conserved 59 domain, a central
domain of tandemly repeated sequence units, and a 39
domain of relatively variable length and sequence. Heavy
glycosylation, primarily of the central and C-terminal Als
domains, and localization of the mature Als proteins in the
C. albicans cell wall, positions them optimally for contact
with host and abiotic surfaces, where they function in
adhesive processes (reviewed by Hoyer et al., 2008).
Since the discovery of the ALS family, efforts have focused
on understanding the role of its multiple encoded proteins.
Earlier approaches included extensive studies of ALS gene
expression patterns in C. albicans cells from cultures,
disease models and human clinical material (reviewed by
Hoyer et al., 2008). Multiple possibilities could be
envisioned, including transcription of a single ALS gene
at one time, resulting in the domination of an individual
Als protein on the C. albicans cell surface, or simultaneous
expression of multiple ALS genes, resulting in the
heterogeneous presence of similar quantities of Als proteins
on the cell. Results from different studies have demon-
strated simultaneous expression of ALS genes in various
specimens, and found that, regardless of the source of the
C. albicans cells, certain ALS genes can be expressed at high
levels while others never rise above a low expression level.
Some genes, such as ALS1, have distinct expression Abbreviation: BEC, buccal epithelial cell.
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studies using wild-type strains and also a PALS1–GFP
reporter construct show a tremendous burst of ALS1
expression when cells from a saturated culture are placed
into fresh growth medium. ALS1 expression levels trail off
as culture growth progresses. In C. albicans cells recovered
from disease models and human clinical specimens, ALS1
expression is detected readily without the temporal
decrease in expression (Green et al., 2004, 2005a, 2006;
Cheng et al., 2005), suggesting the potential for differences
in ALS1 regulation in vitro and in vivo. Because gene
expression data are derived from a population of cells, little
is known about the production of Als1 on individual cells
or its spatial localization or stability on the cell surface. The
observed gene expression data could be consistent with
numerous permutations of these variables.
To determine the cell-surface Als1 patterns that correspond
to the gene expression data, we developed an anti-Als1
mAb. Development of an anti-Als1 mAb is part of a larger
effort to raise a mAb specific for each protein in the Als
family and study Als protein localization on the C. albicans
cell surface. Characterization of an anti-Als3 mAb has been
reported previously (Coleman et al., 2009). Indirect
immunofluorescence of C. albicans cells showed the unique
localization of Als1 on yeast and germ tubes/hyphae, and
the stability of the protein, which resulted in a heteroge-
neous Als1 presence among cultured cells. Analysis of C.
albicans cells recovered from a disease model revealed
differences from cultured cells in Als1 localization,
consistent with ALS1 regulatory differences in vitro and
in vivo.
METHODS
Production of mAbs. mAbs were raised against Pichia pastoris-
produced, hexa-His-tagged fragments from the N-terminal domain of
Als proteins, as described by Coleman et al. (2009). Briefly, Als N-
terminal fragments were secreted into the culture supernatant and
purified by His-Trap column chromatography according to the
manufacturer’s instructions (GE Healthcare). When necessary (for N-
terminal domain fragments of Als2, Als6 and Als9), proteins were
treated with endoglycosidase H (Roche) to remove N-linked carbohyd-
rate. Proteins were analysed by MS to verify their predicted molecular
mass, and visualized by SDS-PAGE and silver staining to confirm the
presence of a single protein band. Als N-terminal domain fragments
were used to immunize BALB/c mice, as described previously (Coleman
et al., 2009). ELISA was used for initial specificity testing (Coleman
et al., 2009). Absorbance values were calculated as A570 subtracted from
A450.Typicalresultsshowedanabsorbancereadingofapproximately0.3
for the reaction between a specific anti-Als hybridoma culture
supernatant and its corresponding immunogen, compared with
background values of ¡0.1. ELISA analysis using protein G-purified
(GE Healthcare) mAb typically produced absorbance readings of
approximately 1.5 with background values of ¡0.1. Western blotting
methods have also been described previously (Coleman et al., 2009). A
mAb specific for Als1 (called 1-B2) was isotyped using the Monoclonal
Antibody Isotyping kit (Pierce) and was IgG1 with a kappa light chain.
mAb–antigen bindingkineticsweremeasured ona Biacore3000Surface
Plasmon Resonance system using an indirect capture method, as
described previously (Coleman et al.,2 0 0 9 ) .
C. albicans strains. Many of the C. albicans strains used in this work
were derived from SC5314 (Gillum et al., 1984), such as CAI4 (iro1-
Dura3::imm434/iro1-Dura3::imm434; Fonzi & Irwin, 1993) and
CAI12, which is a CAI4 derivative (ura3/URA3; Porta et al., 1999).
Strain 1467 (als1D/als1D; Zhao et al., 2004) was constructed from
CAI4. The wild-type large ALS1 allele from strain SC5314 was
reintegrated into 1467 to yield strain 2151 (Zhao et al., 2004). C.
albicans strains of diverse origin and clade assignment (detailed in
Coleman et al., 2009) were also used. These included strains WO-1,
GC15, GC23, 1-28, 2309, SqF087, CrA038 and OKP77. A set of
diverse Candida species was assembled, including Candida dublinien-
sis strains CD36 (from Derek Sullivan, Trinity College, Dublin,
Ireland), CM1 and 16F (from Richard Barton, University of Leeds,
UK), as well as isolates purchased from the American Type Culture
Collection (Candida glabrata ATCC 2001, Candida krusei ATCC
14243, Candida parapsilosis ATCC 22109, Candida lusitaniae ATCC
42720, Candida tropicalis ATCC 201380 and Candida guilliermondii
ATCC 6260).
ALS1 overexpression was accomplished using plasmid 1105 (Green
et al., 2005a), which is a modified version of CIp10 (Murad et al.,
2000). Plasmid 1105 encodes the C. albicans TPI1 promoter and
terminator sequences separated by a polylinker that includes the
restriction sites (59A39) XhoI-SmaI-NotI-BglII. The XhoI-BglII sites
allow cloning for overexpression of any full-length ALS gene due to
the lack of these restriction sites in any of the ALS gene coding
regions. These sites are used in various vectors in the laboratory and
allow interchangeable cloning of ALS genes between different
constructs. The ALS1 large allele was amplified from genomic DNA
of strain 1416, an als1D/ALS1 derivative of strain SC5314, using the
primers ALS5-Xho (59-CCC CTC GAG ATG ATT CAA CAA TTT
ACA TTG TTA TTC C-39) and ALS1-Bgl (59-CCC AGA TCT TCA
CTA AAT GAA CAA GGA CAA TAA TG-39), and Pfu polymerase
according to the manufacturer’s instructions. The XhoI/BglII-digested
fragment was ligated into XhoI/BglII-cut plasmid 1105. The PTPI1–
ALS1 overexpression construct was linearized with HindIII, which
cuts within the 39 end of the ALS1 coding region to direct integration
of the plasmid to the ALS1 locus in strain CAI4. The resulting strain,
2243, was verified by Southern blotting, which indicated that
integration was directed to the large allele locus of strain CAI4 (data
not shown). The growth rate of the overexpression strain was
determined using published methods (Zhao et al., 2004). Briefly,
doubling times were calculated from the linear portion of the growth
curve, which was defined spectrophotometrically. Triplicate data
points in triplicate independent experiments were analysed statist-
ically and showed no difference between the strains (doubling time
for CAI1251.45±0.03 h and for 224351.47±0.03 h).
C. albicans culture conditions. All C. albicans isolates were stored
at –80 uC. Strains were streaked to YPD medium (per litre: 10 g yeast
extract, 20 g peptone and 20 g glucose, with 20 g agar added for
plates) and incubated for 24 h at 37 uC. Plates were transferred to
4 uC and kept for no longer than 1 week. A single colony was
inoculated into 20 ml YPD liquid medium for each starter culture.
The starter culture was incubated at 37 uC with 200 r.p.m. shaking
for 16 h prior to experiments that utilized a 37 uC incubation
temperature. Cells from the starter culture were washed in Dulbecco’s
PBS without calcium or magnesium (DPBS), counted and inoculated
at 1610
6 cells ml
21 into the growth medium appropriate for the
experiment. Starter cultures for experiments that utilized a 30 uC
incubation temperature were grown at 30 uC for 16 h with 200 r.p.m.
shaking, and cells were handled similarly to those grown at 37 uC.
Anti-Als1 immunolabelling experiments were conducted using cells
grown at 37 or 30 uC with equivalent results. For growing germ tubes,
C. albicans yeasts from the YPD starter culture were processed as
detailed above and resuspended into germ tube-inducing medium at
a density of 5610
6 cells ml
21. Media included RPMI 1640 without
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bovine serum, and the medium described by Lee et al. (1975). Details
regarding culture conditions are specified as needed for each
experiment in Results (see below).
Immunolabelling of C. albicans cells. Anti-Als mAbs were used to
immunolabel C. albicans cells from culture, and from homogenized
mouse kidney samples. Methods have been described previously
(Coleman et al., 2009). Routinely, cultured cells were fixed in DPBS
containing 3% paraformaldehyde. Fixed cells were washed in DPBS,
non-specific binding was blocked with normal goat serum, and the
cells were incubated with the primary protein G-purified mAb and
then with a secondary FITC-conjugated antibody. Fluorescence was
detected either by microscopy (see below) or by flow cytometry
(Coleman et al., 2009). For analysis of Als protein production in vivo,
C. albicans cells were isolated from the kidney of a BALB/cByJ mouse
at 28 h post-inoculation. Methods for electron microscopy detection
of immunogold labelling have been described previously (Coleman
et al., 2009).
Three different microscope systems were used to visualize immuno-
labelled cells. The first was an Olympus BX50 FluoView confocal
microscope using Melles Griot argon (488 nm) and krypton
(568 nm) lasers. The second was a Zeiss Axiovert 200M microscope
equipped with a mercury X-Cite illuminator, an ApoTome Structured
Illumination Optical Sectioning system with a VH ApoTome grid
under a weak ApoTome filter setting, standard excitation and
emission filters for FITC and rhodamine, a Plan-Apochromat 663/
1.40 numerical aperture oil objective lens, and an AxioCam MRc 5
colour camera. The third microscope was a Zeiss LSM 710 NLO
confocal scanner, Axio Observer Z1 microscope and a Spectraphysics
Mai Tai Ti:Sapphire laser. Some samples were observed as wet
mounts, while others were embedded in ProLong Gold antifade
reagent (Molecular Probes P36930) in an approximately 1:1 volume
with cells in DPBS, placed on glass slides, coverslipped, and allowed to
set for 24 h. The microscope used for each experiment is specified in
the respective figure legend.
Covalent labelling of the C. albicans cell surface with Alexa
Fluor 594. C. albicans CAI12 cells from a 16 h overnight culture
grown in YPD medium at 30 uC with 200 r.p.m. shaking were washed
three times in 0.1 M sodium bicarbonate buffer (pH 8.3) and then
incubated for 1 h at 25 uC in 1 ml bicarbonate buffer containing
1 mg Alexa Fluor 594 carboxylic acid, succinimidyl ester (Molecular
Probes A-20004) dissolved in 0.1 ml DMSO. After incubation the
cells were washed three times in DPBS, placed in YPD medium at a
density of 1610
6 cells ml
21, and incubated at 30 uC and 200 r.p.m.
Aliquots of cells collected at multiple time points were washed, fixed
and immunolabelled with anti-Als1, as described above. In certain
experiments, C. albicans cells were stained with Calcofluor White
(Sigma). A stock solution (1 mg ml
21) was prepared in 0.1 M Tris/
HCl, pH 9.0, and diluted 1:10 in DPBS as a working solution. Anti-
Als1-labelled C. albicans cells were resuspended in 100 ml Calcofluor
White working solution and incubated at room temperature for
5 min. Cells were washed twice in DPBS prior to microscopic
examination.
Adhesion assays. The ability of the anti-Als1 mAb to inhibit
adhesion of C. albicans to freshly collected human buccal epithelial
cells (BECs) was tested. C. albicans yeasts were grown in YPD medium
for 16 h at 30 uC. Yeasts were washed three times in DPBS, and
inoculated either into YPD to grow yeasts or into RPMI 1640 medium
to grow germ tubes. Germ tube adhesion assays have been described
previously (Beucher et al., 2009). For yeast adhesion assays, 2610
8
cells were inoculated into 20 ml fresh YPD and incubated for 1 h at
30 uC. Cells were collected, washed in DPBS and counted; 2610
6
yeasts were added to a flask containing 4 ml DPBS. Anti-Als1 mAb or
anti-Als6 mAb (isotype-matched negative control; Coleman et al.,
2009) was added to the flask at a final concentration of 20 mgm l
21.
Flasks were incubated for 30 min with 200 r.p.m. shaking and then
2610
4 BECs were added. Following 30 min incubation, BECs were
collected by filtration and processed as described previously (Beucher
et al., 2009). Adhesion of yeasts to BECs was evaluated by microscopy
and the mean number of yeasts adherent to 100 BECs calculated.
Analysis of data from three separate days of experiments has been
described previously (Beucher et al., 2009).
Real-time RT-PCR quantification of ALS1 transcription. Yeasts
from a YPD starter culture (described above) were inoculated into
fresh medium and incubated with shaking at 200 r.p.m. At 1 h
intervals, cells were removed from the culture and collected by
filtration over a 0.45 mm pore-size membrane. Each membrane was
transferred to a 50 ml conical Falcon tube, flash-frozen in a dry ice–
ethanol bath, and stored at 280 uC until RNA was extracted using a
hot phenol method (Hoyer et al., 1995). RNA was treated with
DNase I and the samples were purified using an RNeasy Mini kit
(Qiagen). PCR using primers against genomic DNA sequences was
employed to verify that all detectable DNA was removed from the
RNA preparation. The quality and integrity of the RNA were
checked on a formaldehyde agarose gel (Hoyer et al., 1995). Primers
QRTALS1F and QRTALS1R were used for real-time RT-PCR
analysis of ALS1 gene expression, as described previously (Green et
al., 2005b). Primers QRTTEF1F and QRTTEF1R, which amplify
TEF1, were used as a control. Real-time RT-PCR analyses were run
in triplicate for each time point, and the mean and SD of threshold
values (Ct)g r a p h e d .
RESULTS
Validating the specificity of the anti-Als1 mAb
ELISA was used to select mAb 1-B2 from a panel of
potential anti-Als1 mAb candidates (see Methods). mAb 1-
B2 specificity for Als1 was tested further by immunolabel-
ling of cultured C. albicans cells. Previous studies of ALS1
expression in cultured C. albicans cells showed a large peak
of transcriptional activity after yeasts from a saturated
culture were placed into fresh growth medium, and a
gradual diminishing of measurable transcript abundance as
the culture aged (Green et al., 2005b). Yeasts of control
strain CAI12 were grown to saturation overnight at 37 uC
(16 h) and then transferred to fresh YPD medium for 1 h.
The 1 h yeast cells immunolabelled brightly with the anti-
Als1 mAb, whereas no signal was detected for strain 1467,
in which ALS1 is deleted (Fig. 1). The specificity of the
anti-Als1 mAb was further demonstrated by immunolabel-
ling of the ALS1 reintegrant strain 2151.
Flow cytometry analysis was also used to validate the
specificity of the anti-Als1 mAb (Fig. 2). Similar to the
results observed for immunofluorescence microscopy, flow
cytometry showed a strong fluorescence on yeast cells of
strain CAI12 grown under conditions known to promote
high levels of ALS1 transcription. The als1D/als1D strain
showed fluorescence at a level similar to that of the
negative control (secondary antibody only). Reintegration
of a wild-type ALS1 allele restored anti-Als1 recognition of
the C. albicans cell surface.
Candida albicans cell-surface heterogeneity
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terminal domain fragment from each protein in the Als
family. Production and validation of these fragments have
been detailed by Coleman et al. (2009) and are summarized
in Methods. Western blotting with the anti-Als1 mAb
detected the Als1 N-terminal domain fragment, but none
of the fragments encoded by any other ALS genes,
supporting the conclusions that mAb 1-B2 is specific for
Als1 and that the mAb is useful for Western blotting.
Surface plasmon resonance measurements of binding
kinetics between mAb 1-B2 and the Als1 N-terminal
domain fragment showed dissociation constants (KD)o f
0.3 and 0.5 nM in duplicate experiments (mean50.4 nM).
Anti-Als1 labelling of C. albicans budding yeasts
The cell-surface anti-Als1 labelling pattern appeared
uniform, with the exception of gaps in signal at the poles
of the cell (Fig. 1). The emergence of buds adjacent to the
gaps suggested that Als1 was absent from bud scars. C.
albicans yeasts were labelled with anti-Als1, counterstained
with Calcofluor White and examined by microscopy
(Fig. 4). Fig. 4(a) shows a lateral view of a yeast cell on
which anti-Als1 labelling was missing from the pole.
Intense Calcofluor White staining in this location was
consistent with the presence of a bud scar. Images in Fig.
4(b–d) demonstrate that the Als1-negative portions of the
yeast cell surface were stained intensely with Calcofluor and
conformed to the shape of bud scars.
The persistence of Als1 on the C. albicans yeast cell was
examined by covalently labelling the cell surface with Alexa
Fluor 594 carboxylic acid, succinimidyl ester. CAI12 cells
were grown for 16 h in YPD at 37 uC with 200 r.p.m.
shaking. At this time point, ALS1 transcript levels are very
low (Hoyer et al., 1995, 2008), and cells with detectable
anti-Als1 surface labelling were rare in the culture (Fig. 5a).
The Als1-negative, Alexa 594-positive cells (called
‘inoculum cells’) were placed into fresh YPD medium
and followed over time. After 1 h, the inoculum cells, as
well as their newly formed buds, were positive for Als1
(Fig. 5b). As culture growth progressed and new genera-
tions of buds formed, the Alexa 594-labelled inoculum cells
became relatively less abundant in the culture. Als1-
positive buds arose from Als1-positive mother yeasts until
a time at which Als1-negative buds were observed [white
arrowheads in Fig. 5(c), 4 h post-inoculation]. Four cells in
Fig. 5(c) appeared connected, providing additional infor-
mation regarding the generation that fell below the
detection limit for the immunolabelling assay. The Alexa
594-positive inoculum cell in this group gave rise to two
Als1-positive daughters. The progeny of one daughter was
faintly Als1-positive, suggesting that the daughter of this
cell (the inoculum cell’s great-granddaughter) was likely to
be Als1-negative. At the point when the culture reached
Fig. 1. Immunolabelling of C. albicans yeasts with anti-Als1 mAb demonstrates cell-surface Als1 recognition and specificity of
the mAb. Yeasts from saturated YPD cultures of C. albicans control strain CAI12 (a), 1467 (als1D/als1D) (b) and ALS1
reintegrant strain 2151 (als1D/als1D::ALS1) (c) were transferred to fresh YPD medium for 1 h at 37 6C, immunolabelled with
anti-Als1 and a FITC-conjugated secondary antibody, and viewed with an Olympus BX50 microscope. Upper panels with a
dark background have laser illumination (488 nm); lower panels are illuminated with white light. Lack of Als1 on the mutant
strain and detection of Als1 on the control and reintegrant strains supported the conclusion that the mAb recognized cell-
surface Als1 and was specific for the protein. Bars, 10 mm.
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rare, in the presence of many Als1-negative cells (Fig.
5d). The photomicrograph in Fig. 5(d) was difficult to
obtain and suffers from obvious yeast autofluorescence
that appears similar to that of Als1-positive cells; Als1-
positive cells are indicated by black arrows. Also evident
was a cell with signals of both Als1 and Alexa 594
(asterisk in Fig. 5d). The detection of this cell was
evidence that Als1 deposited on the surface of an
inoculum cell after it was placed into fresh YPD medium
was still present 24 h after the culture was started. Alexa
594-positive, Als1-negative cells were not observed using
this technique.
The image in Fig. 5(c) suggested that the great-grand-
daughters of the inoculum cells were Als1-negative.
Counting cells with respect to their Alexa 594 and anti-
Als1 labelling status provided an additional estimate of the
generation for which the anti-Als1 signal dropped below
the antibody labelling detection limit. Table 1 shows results
from two independent experiments. Counting the percent-
age of Alexa 594-positive cells in the culture over time
provided an estimate of the number of cell divisions that
had occurred at each time point of the experiment. For
example, at 1 h post-inoculation, Alexa 594-positive cells
were approximately 50% of the total cells, suggesting that
one doubling had occurred. By 3 h, Alexa 594-positive cells
were 17% of the population, indicating that inoculum cells
were one of every six cells in the culture. Most
simplistically, this figure can be interpreted to indicate
that between two and three doublings occurred in the 3 h
period. Over this same period of time, the percentage of
Alexa 594-negative, Als1-positive yeasts (progeny of the
inoculum cells) rose in the population to 66% at 3 h. Alexa
594-negative, Als1-negative cells were roughly one in five
cells present at 3 h. These figures were consistent with a
culture population that contained inoculum cells and their
daughters, granddaughters and possibly great-granddaugh-
ters. Counts of cells suggested that Als1-negative cells
were the granddaughters or great-granddaughters of the
inoculum cells. Micrographs suggested a trailing off of the
anti-Als1 signal, as observed in the granddaughter cell in
Fig. 5(c). Real-time RT-PCR quantification of ALS1
transcript levels provided the Ct values that correspond
to the micrographs (Fig. 5e). The variable presence of Als1
on individual yeast cells in the culture provided an
additional measure of heterogeneity in the population.
The above experiment documented the trailing off of the
presence of Als1 on the C. albicans cell surface as sub-
sequent generations grew in a culture, and also the stability
of Als1 on the cell surface over time. The Alexa 594
labelling experiment was repeated to gain a better under-
standing of which generation showed the first decrease
in Als1 abundance. Careful examination of the images in
Fig. 2. Use of flow cytometry to demonstrate anti-Als1 specificity
in populations of C. albicans yeast cells. C. albicans yeast cells of
control strain CAI12, als1D/als1D mutant (1467) and ALS1
reintegrant (2151) strains were grown for 16 h in YPD and then
transferred to fresh YPD for 1 h. Cells were immunolabelled with
anti-Als1 and a FITC-conjugated secondary antibody. Geometric
mean fluorescence (GMF) was measured as described previously
(Coleman et al., 2009). The negative control sample was treated
with the secondary antibody alone. An increased fluorescence
intensity for strains that encoded ALS1 suggested that the mAb
was specific for Als1.
Fig. 3. Western blotting of the N-terminal domain from each
protein in the Als family to demonstrate specificity of the anti-Als1
mAb. N-terminal fragments of each Als protein were produced in
P. pastoris, as described previously (Coleman et al., 2009). Each
fragment had a hexa-histidine tag at its C terminus and was
purified by nickel-affinity chromatography. (a) Approximately
0.5 mg of each purified protein was run on an SDS-PAGE gel
and silver-stained. (b) A second gel with identical lanes, and just
50 ng of each protein, was blotted to a Hybond-P PVDF
membrane and Western-blotted with anti-Als1 at a concentration
of 4.8 mgm l
”1. Recognition of only the Als1 immunogen with the
anti-Als1 mAb further supported the conclusion that the mAb was
specific for Als1.
Candida albicans cell-surface heterogeneity
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less intensely than the inoculum cells. The Alexa 594
labelling experiment was repeated, and this time, the slides
were analysed using the Zeiss LSM 710 confocal system,
which provides the option of false labelling images using
gradations of colour that correspond to differences in
Fig. 4. Anti-Als1 immunolabelling and Calcofluor White staining of C. albicans yeast cells to demonstrate the absence of Als1
localization to the bud scar. C. albicans strain CAI12 from a saturated culture was grown for 1 h in fresh YPD medium at 30 6C
and fixed in paraformaldehyde. Fixed cells were immunolabelled with anti-Als1 and a FITC-conjugated secondary antibody.
Cells were then stained with Calcofluor White, which binds to chitin, accentuating the fungal cell wall and bud scars. Cells were
visualized with a Zeiss LSM 710 microscope. Rows (a–d) show images of Calcofluor-stained cells (left column, false coloured
with cyan), FITC anti-Als1 labelling (second column from left, false coloured with yellow), a merged image (second column from
right) and a bright-field image (right column). FITC labelling demonstrated Als1 on the cell surface with the exception of the bud
scars, which were clearly stained with Calcofluor. Arrows within each bright-field image denote the plane of focus: an arrow with
a tail shows cells with edges in focus, while arrowheads show cells where the cell surface was in focus so that the bud scar
structure could be viewed more readily.
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decreasing cell-surface Als1 abundance on successive generations of yeast culture growth as well as stability of Als1 over
time. Cells from a saturated YPD culture of strain CAI12 were transferred to fresh medium and grown at 30 6C for the
indicated times [0 h, (a); 1 h, (b); 4 h, (c); 24 h, (d)]. In (a–c), replicate photomicrographs of the same image are shown
illuminated with individual or combinations of wavelengths of light, as indicated. A Zeiss Axiovert 200M microscope was used
to image cells. Anti-Als1 mAb was detected by a FITC-conjugated secondary antibody and 488 nm light (488). Alexa 594
covalently linked to the C. albicans cell surface was detected with 594 nm light (594). Bright-field microscopy was used to
visualize all cells in a field (Br). Als1-negative buds are indicated by white arrowheads in (c). The photomicrograph in (d) was
illuminated with all three light sources and shows many Als1-negative yeasts and a rare dual-labelled Als1/Alexa 594-positive
cell (asterisk). Als1-positive cells in (d) are indicated by black arrows. Faint outlines of cells were the result of either
autofluorescence (green) or bleeding of the FITC signal into the 594 channel (purple). Together, the images show that Als1-
positive cells were rare in saturated cultures, that transfer of cells to fresh medium produced a coating of Als1, and that the
protein coat persisted on the cell surface as the culture aged. (e) Real-time RT-PCR quantification of ALS1 transcriptional
activity over the course of culture growth to demonstrate the burst in transcription that occurs following inoculation into fresh
culture medium and the decreasing abundance of ALS1 RNA as culture growth progresses. Data from a representative
biological replicate of the experiment are shown; triplicate data points were gathered for each time point. The threshold value
(Ct) is graphed so that lower values indicate greater RNA abundance. (f) False-coloured image from a replicate time-course
experiment viewed with a Zeiss LSM 710 NLO system. False colouring with a gradient of colour emphasizes the difference in
anti-Als1 labelling intensity between the inoculum yeast (Alexa 594-positive, purple; Als1-positive, cyan gradient) and its
daughter (Als1-positive, cyan gradient). Decreased anti-Als1 labelling intensity suggests that the transcriptional burst occurs
in the inoculum cell and is diluted by cell division in each subsequent generation until anti-Als1 labelling intensity falls below
the limit of detection for the assay.
Candida albicans cell-surface heterogeneity
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showed that the daughter cell was labelled less intensely
than the inoculum cell (Fig. 5f). This image suggested that
the burst of ALS1 transcriptional activity occurred within
the inoculum cell and was reduced by subsequent cell
divisions until Als1 was no longer detectable on the cell
surface of subsequent generations. This result has import-
ant implications for studying the mechanism that regulates
ALS1 transcription in vitro.
Anti-Als1 labelling of C. albicans germ tubes and
hyphae
Surface localization of Als1 was also studied on germ tubes.
The presence of Als1 on germ tubes has been reported
elsewhere (Fu et al., 2002), and immunolabelling with mAb
1-B2 produced a similar result (Fig. 6). Analysis of germ
tubes collected over a time-course of growth showed that
Als1 was visible as early as 10 min following inoculation of
YPD-grown yeasts into RPMI medium (Fig. 6a). On 1 h
germ tubes, Als1 labelling was most intense proximal to the
mother yeast (Fig. 6b). Similar to observations for yeast
forms, Als1 persisted on germ tubes over time and was
visible even after cells formed long hyphae (Fig. 6c, d). On
longer hyphae, additional Als1-positive sections were
observed further down the length of the hypha, but the
signal intensity was considerably more faint than the signal
proximal to the mother yeast. For 85% of the cells
observed, anti-Als1 labelling was detected only on the
longer/longest germ tube to emerge from each mother
yeast. However, other patterns were noted, including
labelling only of the shorter germ tube on a mother yeast
(Fig. 6c) and labelling of each germ tube present (Fig. 6d).
Labelling of the mother yeast was visible, but faint, for C.
albicans strains derived from SC5314 that were grown in
YPD and then inoculated into RPMI medium.
Growth of C. albicans germ tubes in media other than RPMI
revealed growth medium-dependent effects in anti-Als1
labelling (Fig. 6e). In each experiment, yeast cells were grown
in YPD for 16 h and then transferred to another medium to
promote germ tube formation. Germ tubes were grown in
YPD with 10% fetal bovine serum, in DPBS with 10% fetal
bovine serum or in Lee medium, fixed in paraformaldehyde
and immunolabelled with anti-Als1. Growth medium-
dependent differences in anti-Als1 labelling were in intensity,
rather than location of signal. While germ tubes grown in
RPMI medium exhibited only faint labelling of the mother
yeast (Fig. 6b), growth under serum-containing conditions
or in Lee medium resulted in stronger anti-Als1 labelling of
the mother yeast (Fig. 6e). Gaps in labelling appeared to
correspond to bud scars. Labelling of the germ tube for Lee-
grown cells was stronger than for the other growth media.
Immunolabelling of germ tubes with anti-Als1, followed by
treatment with an anti-mouse gold particle-linked antibody
and processing for electron microscopy, visualized Als1 in
the outer flocculant layer of the cell wall (Fig. 7).
Anti-Als1 labelling was also examined on C. albicans cells
from a murine model of disseminated candidiasis. C.
albicans was injected into the mouse tail vein and infection
proceeded for 28 h. Anti-Als1 immunolabelling of C.
albicans cells dissected from homogenized mouse kidney
showed instances of differential labelling between yeast and
hyphae (Fig. 8a), as observed for RPMI-grown germ tubes.
Unlike cultured cells, however, C. albicans hyphae from the
mouse kidney were labelled on a more extensive length of
the cell (Fig. 8b).
Anti-adhesive effects of the anti-Als1 mAb
Anti-Als1 mAb was tested for its ability to inhibit adhesion
of C. albicans to freshly collected human BECs. Growth
conditions that produced the greatest amount of anti-Als1
immunolabelling were examined. Treatment of 1 h yeast
cells with anti-Als1 yielded significantly fewer adherent
yeasts per buccal cell compared with treatment with an
isotype-matched anti-Als6 (1.6±0.3 vs 5.0±0.3; P50.02).
Anti-Als6 was used as a negative control for adhesion
assays because ALS6 expression levels are so low that little
cell-surface protein is present (Coleman et al., 2009).
Adhesion assays using 1 h C. albicans germ tubes produced
similar results. Treatment with anti-Als1 yielded 7.0±0.9
Table 1. Evaluation of Alexa Fluor 594 and anti-Als1 cell-
surface labelling patterns for cultured C. albicans yeasts to






Expt. 1 Expt. 2 Mean
Alexa 594-positive, Als1-positive 1 45% 57% 51%
23 1 % 3 7 % 3 4 %
31 6 % 1 7 % 1 7 %
Alexa 594-negative, Als1-positive 1 46% 41% 44%
25 4 % 5 1 % 5 3 %
36 2 % 7 0 % 6 6 %
Alexa 594-negative, Als1-negative 1 9% 2% 6%
21 5 % 1 2 % 1 4 %
32 2 % 1 3 % 1 8 %
*Inoculum cells were covalently labelled with Alexa 594. At the
indicated time points, cells from the culture were harvested and
immunolabelled with the anti-Als1 mAb and a FITC-conjugated
secondary antibody. Cells were visualized using a Zeiss Axiovert 200M
microscope and evaluated in digital images. The number of cells
evaluated at each time point ranged from 54 to 265, with a mean of
129. Cells considered positive had a visible signal for Alexa 594 and/or
anti-Als1, as tabulated above. The labelling intensity for Alexa 594 was
more consistent than for anti-Als1, suggesting that Als1 protein
abundance varied in an obvious manner on cultured yeast cells. The
variability was likely due to the large increase in transcriptional activity
when cells were placed into fresh growth medium, and the gradual
diminishing of transcriptional activity as culture growth progressed.
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grown in YPD medium for 16 h at 37 6C, washed in DPBS, counted and transferred into pre-warmed RPMI medium at a cell
density of 510
6 cells ml
”1. The culture was sampled at various time points and cells were fixed in paraformaldehyde, as
described previously (Coleman et al., 2009). Fixed cells were immunolabelled with anti-Als1 and a FITC-conjugated secondary
antibody. Cells were imaged using an Olympus BX50 FluoView microscope. Cell-surface Als1 was visible as early as 10 min
following inoculation of the cells into RPMI (a). Anti-Als1 labelling of germ tubes was most intense in the region proximal to the
mother yeast (b). While the longer germ tube/hypha was Als1-positive for most mother yeasts, exceptions were noted, including
labelling of the shorter germ tube/hypha (c), or labelling of each germ tube/hypha (d). In each case, Als1 persisted on the germ
tube/hypha over time. Growth of germ tubes in different culture conditions, such as Lee medium (e), resulted in the same
general pattern of anti-Als1 labelling, with differences in the intensity of labelling of the mother yeast and/or germ tubes (other
patterns not shown). Bars, 10 mm.
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10.9±0.9 for anti-Als6 (P50.02). Inhibition of C. albicans
adhesion using anti-Als1 is consistent with the role of Als1
in adhesion to host cells.
Anti-Als1 labelling of diverse Candida isolates
The anti-Als1 immunolabelling results presented above
used derivatives of C. albicans strain SC5314. Anti-Als1
labelling patterns were examined on a set of eight C.
albicans isolates of diverse clade assignment and collected
from various body sites in either healthy or diseased
humans or animals (Coleman et al., 2009). The collection
included strains WO-1, GC15, GC23, 1-28, 2309, SqF087,
CrA038 and OKP77. Prior to anti-Als1 immunolabelling,
isolates were grown for 16 h in YPD, washed in DPBS and
then transferred into YPD for 1 h or into RPMI for 1 h.
For all isolates, immunolabelling of 1 h yeast cells
produced results similar to those for SC5314-derived
strains, with the exception of strain WO-1, for which a
signal was not detected. Additional work demonstrated
that the 59 domain of the ALS1 coding region was missing
from the WO-1 genome, providing additional support for
the conclusion that the mAb was specific for Als1 (X. Zhao
and others, unpublished results). Immunolabelling of germ
tubes showed the most intense signal on the germ tube
proximal to the mother yeast for each isolate, although the
length of the labelled area varied between strains (data not
shown). Sites of germ tube emergence were also labelled.
Mother yeasts were labelled only faintly following growth
in RPMI, although the labelling intensity varied between
strains.
Isolates of various Candida species were tested to assess
anti-Als1 immunolabelling. Coleman et al. (2009) have
described the set of isolates, which included three strains of
C. dubliniensis, and one isolate each of C. glabrata, C.
krusei, C. parapsilosis, C. lusitaniae, C. tropicalis and C.
guilliermondii. All Candida species were grown as starter
cultures for 16 h in YPD at 37 uC and then transferred to
fresh YPD for 1 h or to RPMI medium for 1 h at 37 uC.
Many of these Candida species do not form germ tubes or
hyphae, so the morphologies observed for C. albicans cells
grown under these standard conditions were not present
for all species tested. Immunolabelling was not detected for
cells from any species or growth conditions using the anti-
Als1 mAb.
Anti-Als1 immunolabelling of an ALS1
overexpression strain
Als1 that is synthesized as C. albicans yeast cells are placed
into fresh culture medium was not incorporated into bud
scars (Figs 1 and 4). This observation raises the question of
whether Als1 can be placed into the cell wall at the location
of a bud scar. This question was addressed by anti-Als1
immunolabelling of an ALS1 overexpression strain (strain
2243; Fig. 9). Constitutive ALS1 expression should result in
Als1 presence on the surface of yeast cells, even at times in
the growth curve when the majority of wild-type cells are
Als1-negative. Fig. 9(a) shows yeast cells of strain 2243
grown in YPD medium for 8 h. Unlike wild-type C.
albicans grown to this time point, each strain 2243 cell was
labelled strongly with anti-Als1, including the poles (Fig.
9a). Calcofluor staining and higher-magnification imaging
verified that Als1 was localized within the bud scars of
strain 2243 (Fig. 9b). Germ tubes grown for 1 h in RPMI
medium showed intense anti-Als1 labelling on both the
mother yeast and germ tube (Fig. 9c).
DISCUSSION
Immunolabelling C. albicans cells with an anti-Als1 mAb
visualized the pattern of Als1 cell-surface localization and
stability that results from previously derived transcriptional
data. Cell-surface Als1 protein abundance is directly related
to ALS1 transcriptional abundance. The ALS1 transcrip-
tional burst that occurs when cells are transferred to fresh
medium results in a near-immediate cell-surface appear-
ance of Als1. For cells that will grow as yeasts, the inoculum
cell is coated in Als1, with the exception of the bud scars.
Daughter cells and successive generations have a less-
intense Als1 presence; this decrease continues as culture
growth progresses. After the second or third generation of
growth, Als1 is not detectable on the yeast cell surface by
indirect immunofluorescence with the anti-Als1 mAb.
Despite their apparent Als1-negative appearance, these
Fig. 7. Electron micrograph of a C. albicans mother yeast–germ
tube junction immunolabelled with anti-Als1 to show Als1
localization in the outer flocculant layer of the germ tube surface.
Strain CAI12 germ tubes were grown in RPMI medium at 37 6C,
immunolabelled with anti-Als1 mAb and a gold-conjugated
secondary antibody, embedded and sectioned for electron
microscopy. Arrows in the higher-magnification inset highlight
gold particles.
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Als1 on inoculum cells, even after that culture has reached
saturation, demonstrates the stability of Als1 on the cell
surface. Together, these data define a range of cell-surface
Als1 abundance that varies from substantial to
undetectable; the relative proportion of these cell types in
the culture population varies over the stages of culture
growth.
Intense anti-Als1 labelling was also noted as a germ tube
emerged from the mother yeast. For the majority of cells,
Als1 was found on the longest germ tube, although
considerable variation was observed among multiple
projections from the same mother yeast. It is open for
debate whether anti-Als1-labelled subsequent projections
from a mother yeast are germ tubes or pseudohyphae.
Production of pseudohyphae from the mother yeast may
trigger another burst of ALS1 transcription that is sufficient
to produce Als1 on the new cell growth. Detection of a
pseudohypha-specific cell-surface protein would clarify
questions regarding morphology; however, recent work
suggests that C. albicans may not produce a protein that
uniquely identifies the pseudohyphal growth form (Carlisle
et al., 2009).
One notable feature of Als1 on the yeast cell surface is its
absence from bud scars. Most yeast cells in a saturated
culture have divided at least once, leaving one, and for
many cells, several, bud scars. Transfer of these cells into
fresh medium, and the subsequent burst of ALS1
transcriptional activity, produces Als1 protein that is then
distributed over the cell surface, with the exception of the
bud scar(s). The bud scar structure is different from the
remainder of the cell wall. Extensive investigations into
Saccharomyces cerevisiae cell division processes, and
conservation of major molecular elements between S.
cerevisiae and C. albicans, allow S. cerevisiae to serve as a
guide for C. albicans cell division (reviewed by Bi, 2001;
Walther & Wendland, 2003; Sudbery et al., 2004). In S.
cerevisiae, C. albicans and other yeasts, selection of the site
of new bud production occurs in late G1 of the cell cycle
with the deposition of septins that form a ring and act as a
scaffold for many proteins involved in cytokinesis,
including an actomyosin ring and localization of chitin
synthase enzymes (DeMarini et al., 1997; Bi, 2001;
Warenda & Konopka, 2002). Microscopically visible cell
budding in C. albicans begins with a bulge in the cell wall
due to the synthesis and deposition of new wall material
(Rico et al., 1991). After cell division, the wall of C. albicans
Fig. 8. Anti-Als1 immunolabelling of C. albicans recovered from murine kidney tissue shows similarities and differences with
respect to immunolabelling of cultured cells. A BALB/cByJ mouse was inoculated via the lateral tail vein with 510
5 cells of C.
albicans strain CAI12. At 28 h post-inoculation, the kidneys were removed, minced with a razor blade, and then homogenized. A
portion of the supernatant was treated with anti-Als1 mAb and an FITC-conjugated secondary antibody. Cells were imaged
using an Olympus BX50 FluoView microscope. Images were illuminated with laser only (488 nm; left panel), white light (right
panel) or both (centre panel). (a) Similar to cultured cells, hyphae were labelled with anti-Als1, but yeast cells were not (white
arrow); however, yeast cells were difficult to find in the kidney tissues. (b) Although Als1-negative hypha segments were
observed (white arrow), Als1 was detected on a much larger area of the surface of hyphae recovered from kidney tissue.
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thickened wall regions of increased chitin content (Mitchell
& Soll, 1979). In C. albicans, the morphology of chitin
microfibrils in bud scars and primary septa differs from that
of microfibrils present in most of the cell wall. Bud scars and
primary septa contain networks of longer interlaced
microfibrils, while the majority of cell wall chitin microfibils
are short microcrystalline rodlets (Lenardon et al., 2007). In
yeast, newly synthesized cell wall material is deposited
centripetally at the neck that separates mother and bud cell,
forming a septum that splits down the middle after
cytokinesis, allowing the cells to separate (Bi, 2001). In C.
albicans, formation of an electron-lucent primary transverse
septum is followed by electron-dense mother and bud
secondary septa that form on either side of the primary
septum (Shannon & Rothman, 1971).
After yeast cell division, the septin scaffold rings dis-
assemble prior to formation of new rings for subsequent
cell division events (Warenda & Konopka, 2002), suggest-
Fig. 9. C. albicans yeast and germ tubes overexpressing ALS1 have a uniform cell-surface coat of Als1, even within bud scars.
Strain 2243, which overexpressed ALS1 under the control of the constitutive, high-activity TPI1 promoter, was grown in YPD
for 16 h at 30 6C and transferred to fresh culture medium. (a) Yeast cells from 8 h growth at 30 6C in fresh YPD medium were
fixed in paraformaldehyde and immunolabelled with anti-Als1 and a FITC-conjugated secondary antibody. In contrast to the
labelling pattern of the control C. albicans strain CAI12 (Fig. 1), yeast forms of the ALS1 overexpression strain were labelled
strongly at the poles of the cell, suggesting Als1 localization within bud scars. This conclusion was strengthened by observation
of overlapping fluorescent signals from anti-Als1 immunolabelling and Calcofluor White staining (b). From left, a Calcofluor-
stained cell false coloured with cyan, FITC anti-Als1 labelling false coloured yellow, the merged image, and a bright-field image.
(c) YPD-grown 16 h yeast cells of strain 2243 were inoculated into RPMI medium for 1 h to produce germ tubes. Strong anti-
Als1 immunolabelling was observed over the surface of the mother yeast and the entire germ tube. All images were produced
using a Zeiss LSM 710 microscope.
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division in contrast to the permanent bud scars present in
the wall. However, there is evidence that bud scar
composition is more complex than simply differences in
cell wall chitin microfibrils. Several studies have shown in
both S. cerevisiae and C. albicans that new bud scars occur
near but do not overlap previous bud scars (Chaffin, 1984;
Chant & Pringle, 1995; Herrero et al., 1999), suggesting the
presence of bud scar-associated intracellular signalling
molecules that prevent septin localization. The significance
of the lack of Als1 protein in bud scars is unknown, but
may indicate spatial regulation of protein localization at
these sites. Immunolabelling with an anti-Als4 mAb shows
Als4 within bud scars, suggesting the possibility of specific
localization signals for the various proteins in the Als
family (D. A. Coleman and others, unpublished results).
However, temporal regulation of Als1 protein production
in the mother yeast late in the cell cycle could also account
for Als1 absence from the bud scar. Overexpression of
ALS1 under the control of the highly active, constitutive
TPI1 promoter leads to Als1 localization in bud scars,
demonstrating that bud scar localization is possible,
although localization is differential when natural amounts
of Als1 protein are produced. Although the function of
Als1 is most commonly discussed in terms of adhesion,
recent work suggests another phenotype evident in als1D/
als1D strains: decreased cell size (X. Zhao and others,
unpublished results). The small-cell-size phenotype sug-
gests a role for Als1 in cell size homeostasis, an idea that is
consistent with a role in cell division and perhaps
differential localization on the yeast cell surface that
excludes bud scars.
Other examples of differential localization with respect to
bud scars are found in the yeast literature. Pir (proteins
with internal repeats) proteins in S. cerevisiae are GPI-
independent alkali-sensitive cell wall proteins that appear
to function in cell wall stability (Sumita et al., 2005). Two
of the four Pir proteins, Pir1 and Pir2, are localized only
to S. cerevisiae bud scars, while Pir3 and Pir4 are found
diffusely over the cell surface irrespective of bud scars.
Signals in the C-terminal region of Pir1 are responsible for
its localization to bud scars. C. albicans has only one Pir
protein, Pir1 (Martı ´nez et al.,2 0 0 4 ) .P i r 1i nC. albicans is
a cell wall protein similar in sequence to Pir4 in S.
cerevisiae. The localization of Pir1 on the C. albicans cell
surface is not known, and it may have a role in cell wall
organization, based on observed increases in PIR1
expression during protoplast regeneration (Martı ´nez
et al., 2004).
For both the yeast and germ tube morphologies, the sharp
increase in Als1 production immediately following transfer
to fresh growth medium is a common link. The signal or
signals initiating ALS1 transcription have been studied in
far more detail in the context of germ tube growth, most
likely due to a widespread misconception in the Candida
literature that ALS1 transcription is specific for that growth
form. Germ tube induction is a complex process. Multiple
factors influence or regulate the process, including CPH1,
CPH2, CZF1, EFG1, FLO8, NRG1, RAS1, RFG1, TEC1,
TUP1 and UME6; UME6 is proposed as a central regulator
of hypha formation downstream of the other factors
(Banerjee et al., 2008; Zeidler et al., 2009). Several hypha-
associated genes regulate ALS1 expression, including EFG1
(Braun & Johnson, 2000; Fu et al., 2002), BCR1 (Nobile &
Mitchell, 2005) and TOR1, an upstream negative regulator
of BCR1 and EFG1 (Bastidas et al., 2009). Deletion of TUP1
and CPH1, two genes related to filamentation, does not
affect ALS1 expression (Braun & Johnson, 2000; Fu et al.,
2002). YAK1 functions upstream of TUP1 and influences
ALS1 transcription (Goyard et al., 2008). Investigations
into ALS1 regulation in yeast will determine whether
shared or unique regulatory proteins function in yeast and
germ tubes.
The anti-Als1 immunolabelling patterns are different on
cells cultured in vitro compared with those recovered from
a disease model. Previously characterized ALS1 transcrip-
tional patterns are consistent with this observation.
Compared with the transcriptional burst and decline that
is observed in vitro (Fig. 5e), ALS1 is detected consistently
in C. albicans cells from disease models and human
clinical material. The measurements were qualitative,
rather than quantitative, but demonstrate ALS1 transcript
in conditions where other ALS gene transcripts could not
be detected. These conditions included oral scrapings
from six HIV-positive patients with signs of oral
candidiasis, oral tissues from a hyposalivatory rat model
of oral candidiasis at 3 and 5 days post-inoculation,
vaginal epithelium and discharge from women who had
fungal elements present on direct microscopic examina-
tion, a murine model of vaginal candidiasis at day 4 and 7,
vaginal, buccal and oesophageal reconstituted human
epithelium at 12, 24 and 36 h of incubation with C.
albicans, as well as model denture and catheter biofilms
(Green et al., 2004, 2006; Cheng et al.,2 0 0 5 ) .ALS1
transcriptional activity was the most readily detected
among genes in the ALS family in kidney tissue from the
murine model of disseminated disease when assayed at 12,
24 and 48 h post-infection (Green et al.,2 0 0 5 a ) .
Collectively, these observations suggest that ALS1 regu-
lation in vivo is different from that in vitro. A study of C.
albicans growth in the murine intestinal tract showed
Efg1-independent expression of genes that are Efg1-
regulated in vitro (White et al., 2007). Since Efg1 regulates
ALS1 in vitro (Fu et al., 2002), perhaps this relationship
accounts for the differences observed in vivo. Because anti-
Als1 immunolabelling results are obviously different
between in vitro-a n din vivo-grown C. albicans cells, in
vitro immunolabelling data will be of limited use to
explain Als1 function in host–C. albicans interactions.
Immunolabelling of cells harvested from additional
disease models and perhaps from human clinical speci-
mens is clearly the next step required to better under-
stand the production and function of Als1 in host
environments.
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